Prostate Cancer Screening Study of 50-75 year old men using the combination test of Circulating Tumour Cells (CTC) and Prostate-Specific Markers

Not Applicable

Completed

• Conditions: prostate cancer; Cancer - Prostate

• Registration Number: ACTRN12620000793910
• Lead Sponsor: AProf Dr Karin Ried

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2020-08-07
• Study Completion: 2022-12-23
• Last Update Posted: 27 March 2023

Recruitment & Eligibility

• Status: Completed
• Sex: Male
• Target Recruitment: 300

Inclusion Criteria

Men 50-75 years old
Primary group 1: men not diagnosed with cancer
Group 2: men diagnosed with prostate cancer (Test will provide probability of relapse or tumour progression)

Exclusion Criteria

men diagnosed with other cancers

Study & Design

• Study Type: Observational
• Study Design: Not specified